Who owns CNTA? 13F holders and whale ownership
CNTA is tracked across public portfolios in Whale Analyzer. This page answers who owns CNTA, which top funds are buying CNTA, aggregate disclosed value, and recent position changes based on public data. Joseph Edelman is the largest reported holder at $209M; the top five funds control 100.0% of reported ownership; institutions were net buying last quarter (3 increased, 0 reduced); the stock trades above the aggregate whale cost basis of $13.5. Top tracked holders include Joseph Edelman, Lee Ainslie, Alpine Associates, and Baker Bros. Advisors.
Continue to the live CNTA dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Joseph Edelman 13F portfolio Perceptive Advisors holdings | $208.9M | 5.3M | Increased |
| Lee Ainslie 13F portfolio Maverick Capital holdings | $73.7M | 1.9M | Increased |
| Alpine Associates 13F portfolio Alpine Associates Management holdings | $34.4M | 865.5K | New |
| Baker Bros. Advisors 13F portfolio Baker Bros. Advisors holdings | $26.6M | 670.8K | Held |
Ownership concentration
Reported ownership of CNTA is highly concentrated across tracked institutions.
- Single largest holder: 60.8% of reported ownership
- Top 5 holders: 100.0%
- Top 10 holders: 100.0%
Whale activity this quarter
Across 4 tracked institutions, 3 increased, 1 held. Net positioning is net buying.
- Joseph Edelman — Perceptive Advisors ($208.9M) (▲ 80.2% qoq shares) · avg cost $6.55
- Lee Ainslie — Maverick Capital ($73.7M) (▲ 12.8% qoq shares) · avg cost $22.13
- Alpine Associates — Alpine Associates Management ($34.4M) · avg cost $22.20
- Baker Bros. Advisors — Baker Bros. Advisors ($26.6M) (→ 0.0% qoq shares) · avg cost $32.91
Whale cost basis vs current price
The aggregate tracked cost basis is $13.50 versus a current price of $40.50, so CNTA trades above its cost basis (+200.0%). Average unrealized P&L across tracked holders: 172%.
Sector positioning — Health Care
CNTA sits within the Health Care sector alongside 221 other tracked names. Compare whale ownership across peers:
How to use this page
Values are reported public positions from tracked 13F filers and disclosures — not real-time ownership totals. Open the live CNTA dashboard for price charts and cross-investor scans, or read the SEC 13F guide.
Related stock holder pages
- PRAX whale holders — PRAXIS PRECISION MEDICINES I
- CELC whale holders — CELCUITY INC
- ASND whale holders — ASCENDIS PHARMA A/S
- ROIV whale holders — ROIVANT SCIENCES LTD
- RYTM whale holders — RHYTHM PHARMACEUTICALS INC
- SYRE whale holders — SPYRE THERAPEUTICS INC
- NUVL whale holders — NUVALENT INC
- EWTX whale holders — EDGEWISE THERAPEUTICS INC
Learn more in Whale Analyzer Academy
Deepen your read on CNTA with these Whale Analyzer Academy guides:
Frequently asked questions
Who owns CNTA stock?
Whale Analyzer tracks 4 public institutional holders of CNTA with a combined reported value of $343.6M. See the holder table above for the largest tracked positions.
Which top funds are buying CNTA?
Tracked institutions were net buying last quarter — 3 increased, 1 held. Check the "Change" column: "New" = fresh position, "Increased" = added, "Reduced" = trimmed.
How concentrated is CNTA ownership?
The top five tracked holders report 100.0% of aggregate ownership.
Is CNTA above or below the whale cost basis?
The aggregate tracked cost basis is $13.50 versus a current price of $40.50 (+200.0%).
What does 13F ownership mean for CNTA?
Use the interactive CNTA dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.